ALLURECRYSTALTHERAPY Trademark

Trademark Overview


On Tuesday, February 27, 2024, a trademark application was filed for ALLURECRYSTALTHERAPY with the United States Patent and Trademark Office. The USPTO has given the ALLURECRYSTALTHERAPY trademark a serial number of 98424017. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, September 23, 2024. This trademark is owned by Julio Hofmann. The ALLURECRYSTALTHERAPY trademark is filed in the Medical Instrument Products category with the following description:

Medical apparatus, namely, electric heating devices for curative treatment
allurecrystaltherapy

General Information


Serial Number98424017
Word MarkALLURECRYSTALTHERAPY
Filing DateTuesday, February 27, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, September 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkALLURE CRYSTAL THERAPY
Goods and ServicesMedical apparatus, namely, electric heating devices for curative treatment

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, February 27, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameJulio Hofmann
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLake Mary, FL 32746

Trademark Events


Event DateEvent Description
Tuesday, February 27, 2024NEW APPLICATION ENTERED
Monday, July 8, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 16, 2024ASSIGNED TO EXAMINER
Monday, September 23, 2024NON-FINAL ACTION E-MAILED
Monday, September 23, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 23, 2024NON-FINAL ACTION WRITTEN